HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Martin Davies Selected Research

amiselimod

6/2022A phase II, Multicentre, Randomised, Double-Blind, Placebo-controlled Study to Evaluate Safety, Tolerability, and Efficacy of Amiselimod in Patients with Moderate to Severe Active Crohn's Disease.
10/2018Two-year results from a phase 2 extension study of oral amiselimod in relapsing multiple sclerosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Martin Davies Research Topics

Disease

1Crohn Disease (Crohn's Disease)
06/2022
1Multiple Sclerosis
10/2018
1Bradycardia
10/2018
1Relapsing-Remitting Multiple Sclerosis
10/2018
1Congenital Abnormalities (Deformity)
12/2010
1ST Elevation Myocardial Infarction
11/2006
1Heart Failure
06/2004
1Diastolic Heart Failure
06/2004
1Alcoholism (Alcohol Abuse)
07/2003

Drug/Important Bio-Agent (IBA)

2amiselimodIBA
06/2022 - 10/2018
1sphingosine 1-phosphate (sphingosine-1-phosphate)IBA
10/2018
1antineoplaston A10 (A 10)IBA
12/2010
1caldaretIBA
11/2006
1CalciumIBA
06/2004
1MCC 135IBA
06/2004
1Ethanol (Ethyl Alcohol)IBA
07/2003

Therapy/Procedure

1Percutaneous Coronary Intervention
11/2006